Identification of a novel Circulating Recombinant Form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G

AIDS Research and Human Retroviruses

Volumn 23, Issue 8, 2007, Pages 1008-1019

  Powell, Rebecca L R ^a   Zhao, Jiangqin ^b   Konings, Frank A J ^a   Tang, Shixing ^b   Nanfack, Aubin ^c   Burda, Sherri ^a   Urbanski, Mateusz M ^a   Saa, D R ^d   Hewlett, Indira ^b   Nyambi, Phillipe N ^a,e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Laboratoire de Sante Hygiene Mobile   (Cameroon)

^d MINISTRY OF PUBLIC HEALTH   (Cameroon)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CAMEROON; EVOLUTION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS STRAIN; VIRUS TYPING;

ADULT; BASE SEQUENCE; CAMEROON; FEMALE; GENES, VIRAL; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; VARIATION (GENETICS);

EID: 34848914328     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0289     Document Type: Article

References (39)

1. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal. Science 2000;288:55-56.
2. Dougherty JP and Temin HM. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol 1988;62:2817-2822.
3. Clavel F, Hoggan MD, Willey RL, Strebel K, Martin MA, and Repaske R: Genetic recombination of human immunodeficiency virus. J Virol 1989;63:1455-1459.
4. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
5. Perelson AS, Neumann AU, Markowitz M, Leonard JM, and Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586.
6. Levy DN, Aldrovandi GM, Kutsch O, and Shaw GM: Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci USA 2004;101:4204-4209.
7. Chao L: Fitness of RNA virus decreased by Muller's ratchet. Nature 1990;348:454-455.
8. Temin HM: Sex and recombination in retroviruses. Trends Genet 1991;7:71-74.
9. Korber B, et al., Eds.: HIV Immunology and Sequence Databases. Los Alamos National Laboratory, Los Alamos, NM. Available at: www.hiv.lanl.gov; 2004.
10. McCutchan F: HIV/AIDS. Molecular Epidemiology of Infectious Diseases. Edward Arnold Limited, London, 2000.
11. Carr JK, Torimiro JN, Wolfe ND, et al.: The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology 2001;286:168-181.
12. Burda ST, Konings FA, Williams CA, Anyangwe C, and Nyambi PN: HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common. AIDS Res Hum Retroviruses 2004;20: 1358-1363.
13. Montavon C, Toure-Kane C, Liegeois F, et al.: Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 2000;23:363-374.
14. Nyambi P, Heyndrickx L, Vereecken K, et al.: Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS 2002;16:295-296.
15. Carr JK, Salminen MO, Albert J, et al.: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998;247:22-31.
16. Liitsola K, Tashkinova I, Laukkanen T, et al.: HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-1919.
17. Lukashov VV, Huismans R, Rakhmanova AG, et al.: Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res Hum Retroviruses 1999;15:1577-1583.
18. Nyambi P, Zekeng L, Kenfack H, et al.: HIV infection in rural villages of Cameroon. J Acquir Immune Defic Syndr 2002;31:506-513.
19. Zhong P, Burda S, Urbanski M, et al.: HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon. J Acquir Immune Defic Syndr 2002;31:495-505.
20. Zhong P, S BU, Konings F, et al.: Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: Further evidence of broad HIV type 1 genetic diversity. AIDS Res Hum Retroviruses 2003;19:1167-1178.
21. Konings FA and Nyambi PN: V1181 substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon. AIDS Res Hum Retroviruses 2004;20:673-678.
22. Konings FA, Haman GR, Xue Y, et al.: Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr 2006;42:331-341.
23. Thomson MM, Delgado E, Herrero I, et al.: Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002;83:107-119.
24. Schocketman G, Subbarao S, and Kalish M: Methods for studying genetic variation of the human immunodeficiency virus (HIV). In: Viral Genome Methods. CRC Press, Boca Raton, FL, 1996.
25. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
26. Kumar S, Tamura K, and Nei M: MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5:150-163.
27. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-120.
28. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-425.
29. Felsenstein J: Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985;39:783-791.
30. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160.
31. Felsenstein J: PHYLIP - Phylogeny Inference Package (Version 3.2). Cladistics 1989;5:164-166.
32. Kijak GH, Sanders-Buell E, Wolfe ND, et al.: Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa. AIDS Res Hum Retroviruses 2004;20:521-530.
33. McCutchan FE, Sankale JL, M'Boup S, et al.: HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res Hum Retroviruses 2004;20:819-826.
34. Choi DJ, Dube S, Spicer TP, Slade HB, Jensen FC, and Poiesz BJ: HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant. AIDS Res Hum Retroviruses 1997;13:357-361.
35. Howard TM and Rasheed S: Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. AIDS Res Hum Retroviruses 1996;12:1413-1425.
36. Konings FA, Burda ST, Urbanski MM, Zhong P, Nadas A, and Nyambi PN: Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. J Med Virol 2006;78:523-534.
37. Njai HF, Gali Y, Vanham G, et al.: The predominance of human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology 2006;3:40.
38. Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1: Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee Geneva, 21-23 February 2000. AIDS 2001;15:W1-W25.
39. Thomson MM, Perez-Alvarez L, and Najera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002;2:461-471.